Resumen

The present invention provides a novel series of compounds of general formula (I) and (II) belonging to a wide family of heterocyclic derivatives that exhibit activity for treating diseases in which PDE7 inhibition is therapeutic, preferably for inflammatory, autoimmune and neurodegenerative diseases. The invention also relates to heterocyclic compounds, and to the method for the production thereof, said compounds being widely applicable as drugs or drug candidates.